APA (7th ed.) Citation

X, Q., G, L., H, T., X, Y., J, H., Q, C., . . . Q, X. (2026). Evaluation of the lipid accumulation product for MASLD risk stratification in type 2 diabetes: Establishing sex-specific thresholds and clinical utility. Cardiovascular diabetology, 25(1), . https://doi.org/10.1186/s12933-026-03205-0

Chicago Style (17th ed.) Citation

X, Qu, et al. "Evaluation of the Lipid Accumulation Product for MASLD Risk Stratification in Type 2 Diabetes: Establishing Sex-specific Thresholds and Clinical Utility." Cardiovascular Diabetology 25, no. 1 (2026). https://doi.org/10.1186/s12933-026-03205-0.

MLA (9th ed.) Citation

X, Qu, et al. "Evaluation of the Lipid Accumulation Product for MASLD Risk Stratification in Type 2 Diabetes: Establishing Sex-specific Thresholds and Clinical Utility." Cardiovascular Diabetology, vol. 25, no. 1, 2026, https://doi.org/10.1186/s12933-026-03205-0.